Perilipin 2 (Plin2), a protein associated with the metabolism of intracellular lipid droplets (LDs), has long been considered only for its role in lipid storage. However, the manipulation of its expression affects the severity of a variety of metabolic and age-related diseases, such as fatty liver, insulin resistance and type 2 diabetes (T2D), cardiovascular disease, atherosclerosis, sarcopenia, and cancer, suggesting that this protein may play a role in these pathological conditions. In particular, its downregulation in mice prevents or mitigates some of the above mentioned diseases. Conversely, in humans high levels of Plin2 are present in sarcopenia, hepatic steatosis, atherosclerosis, and some types of cancer. We propose that inhibition of Plin2 might be a strategy to counteract several metabolic and age-related diseases.

Perilipin 2 and Age-Related Metabolic Diseases: A New Perspective / Conte, Maria; Franceschi, Claudio; Sandri, M; Salvioli, Stefano. - In: TRENDS IN ENDOCRINOLOGY AND METABOLISM. - ISSN 1043-2760. - STAMPA. - 27:12(2016), pp. 893-903. [10.1016/j.tem.2016.09.001]

Perilipin 2 and Age-Related Metabolic Diseases: A New Perspective.

CONTE, MARIA;FRANCESCHI, CLAUDIO;SALVIOLI, STEFANO
2016

Abstract

Perilipin 2 (Plin2), a protein associated with the metabolism of intracellular lipid droplets (LDs), has long been considered only for its role in lipid storage. However, the manipulation of its expression affects the severity of a variety of metabolic and age-related diseases, such as fatty liver, insulin resistance and type 2 diabetes (T2D), cardiovascular disease, atherosclerosis, sarcopenia, and cancer, suggesting that this protein may play a role in these pathological conditions. In particular, its downregulation in mice prevents or mitigates some of the above mentioned diseases. Conversely, in humans high levels of Plin2 are present in sarcopenia, hepatic steatosis, atherosclerosis, and some types of cancer. We propose that inhibition of Plin2 might be a strategy to counteract several metabolic and age-related diseases.
2016
Perilipin 2 and Age-Related Metabolic Diseases: A New Perspective / Conte, Maria; Franceschi, Claudio; Sandri, M; Salvioli, Stefano. - In: TRENDS IN ENDOCRINOLOGY AND METABOLISM. - ISSN 1043-2760. - STAMPA. - 27:12(2016), pp. 893-903. [10.1016/j.tem.2016.09.001]
Conte, Maria; Franceschi, Claudio; Sandri, M; Salvioli, Stefano
File in questo prodotto:
Eventuali allegati, non sono esposti

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/574339
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 47
  • Scopus 89
  • ???jsp.display-item.citation.isi??? 84
social impact